Active Gastrointestinal and Other Cancers Grants

PI Name Organization - Company Title Major Program / Research Group FOAsort ascending
Lipkin, Steven M Weill Medical Coll Of Cornell Univ (PQ1) Adaptive immune and microbial mechanisms regulating Lynch syndrome penetrance RFA-CA-17-017: Research Answers to NCI's Provocative Questions
Vilar-Sanchez, Eduardo University Of Tx Md Anderson Can Ctr Uncovering the Role of Colorectal Stem Cells on Disease Penetrance in Lynch Syndrome RFA-CA-15-008: Research Answers to NCI's Provocative Questions
Malafa, Mokenge P H. Lee Moffitt Cancer Ctr & Res Inst Novel Therapy to Inhibit IPMN Progression PAR-21-035: Cancer Prevention and Control Clinical Trials Grant Program
Katona, Bryson William University Of Pennsylvania Defining the phenotype and cancer penetrance of CTNNA1 loss-of-function germline variants PAR-20-292: NCI Clinical and Translational Exploratory/Developmental Studies
El-Serag, Hashem B Baylor College Of Medicine Prevention of Hepatocellular Carcinoma Related to Metabolic Syndrome PAR-20-077: National Cancer Institute Program Project Applications
Chan, Andrew T Massachusetts General Hospital Precision Prevention Research Program PAR-19-349: NCI Outstanding Investigator Award
Chang, Su-Hsin Washington University Addressing racial disparities in monoclonal gammopathy of undetermined significance and progression to multiple myeloma from a prevention perspective PAR-19-279: Provocative Questions (PQs) in Multiple Myeloma Disparities Research
Schmit, Stephanie L Cleveland Clinic Lerner Com-Cwru Variation in tumor-associated immune profiles and colorectal cancer outcomes PAR-18-654: Basic Research in Cancer Health Disparities
Chan, Andrew T Massachusetts General Hospital Effects of inflammaging on intestinal epithelial cells and aspirin chemoprevention. PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program
Allen, Peter J Duke University Preventing an Incurable Disease: The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial) PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program
Vilar-Sanchez, Eduardo University Of Tx Md Anderson Can Ctr Cancer Immune-Interception for Lynch Syndrome PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program
Chung, Raymond T Massachusetts General Hospital Trial of Statins for Chemoprevention in Hepatocellular Carcinoma PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program
Markowitz, Sanford D. Case Western Reserve University Targeting 15-Prostaglandin Dehydrogenase (15-PGDH) in Cancer Risk, Prevention, and Treatment PAR-15-342: NCI Outstanding Investigator Award
Wang, Thomas D University Of Michigan At Ann Arbor Early Targets in Progression of Barrett's Esophagus to Esophageal Adenocarcinoma Barrett's Esophagus Translational Research Network PA-20-272: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
Chak, Amitabh Case Western Reserve University Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma Barrett's Esophagus Translational Research Network PA-20-272: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)

Pages